baber/WOPTO huggingface dataset:
Patent NZ-514895-A (NZ)
Title: Use of the anti-progestagen ORG 33245 administrated intermittently with a daily dosage of a progestagen in combined therapy
Inventor: COELINGH BENNINK HERMAN JAN TI
IPC: A61P15/00
Filed: 2000-04-25
Abstract: A method of contraception comprises daily administering to a female of childbearing age a contraceptively effective amount of a progestagen and intermittently administering the anti-progestagen Org 33245 having the formula (I). The anti-progestagen can be administered on days 1 to 4 or on days 1 to 7 in a cycle of 28 to 32 days.
Patent NZ-517781-A (NZ)
Title: Therapies for chronic renal failure using one or more integrin antagonists
Inventor: ALLEN ANDREW
IPC: A61K48/00
Filed: 2000-09-14
Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of an anti-VLA4 antibody homolog as an integrin antagonist.
Patent NZ-522225-A (NZ)
Title: Triaryl cation antibiotics from environmental DNA
Inventor: HANDELSMAN JO E
IPC: C12P17/16
Filed: 2001-04-25
Abstract: Described are compounds of formulae I and II, wherein: R is H, halo, hydroxy, amino, or optionally substituted alky, and R' is H, halo, amino, or optionally substituted alkyl. Also described is the isolated polypeptide shown in SEQ. ID. NO. 1, which may be used to produce the compounds of formulae I and II. The compounds of formulae I and II are used in the manufacture of medicaments for the treatment of bacterial or fungal infections.
Patent NZ-524677-A (NZ)
Title: Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the extravasation of drugs administered by intravenous routes
Inventor: MUGGETTI LORENA
IPC: A61P43/00
Filed: 2001-09-07
Abstract: Arginine is used in the preparation of a medicament for the prevention and treatment of the side effects associated with the extravasation of drugs administered by intravenous route. Arginine may also be used with an antineoplastic agent in the preparation of an antitumor medicament for intravenous administration for preventing and treating the side effects associated with the extravasation of the antineoplastic agent. Also disclosed is a intravenous formulation comprising arginine and an antineoplastic agent selected from doxorubicin, epirubicin, idarubicin, daunorubicin, alkylcyclin (4-demethoxy-3'-deamino-3'-aziridinyl-4'-mehtylsulfonyl-daunorubicin), paclitaxel, docetaxel, Sugen SU-5416 and Sugen SU-6668.
Patent NZ-525809-A (NZ)
Title: Slowly digestible starch product
Inventor: SHI YONG-CHEN
IPC: A23L7/10
Filed: 2003-05-13
Abstract: A starch composition prepared from low amylose starch comprising crystalline linear á-glucans characterised by: (a) at least about 20% slowly digestible starch; (b) less than about 60% rapidly digestible starch; (c) a melting point temperature, Tp as measured b DSC, of at least about 70°C; and (d) an enthalpy, ÄH as measured by DSC, of at least about 25J/g wherein the composition is at least about 90% debranched, a process for making the composition and an edible product comprising the composition.
Patent NZ-526607-A (NZ)
Title: Automated system for coating the human body: virtual motion
Inventor: LAUGHLIN THOMAS J
IPC: B05B15/12
Filed: 2003-06-20
Abstract: In a system for coating human skin, a coating composition, such as a medical or cosmetic formulation, for example an artificial tanning material, is uniformly coated over the entire body or selected parts of the body surface of the person being coated. The system includes atomization of the coating composition, containment of the atomized spray, and residual recovery which together yield a method for applying coating compositions.
Patent NZ-527043-A (NZ)
Title: Wind energy unit comprising a hollow shaft for rotor hub and generator
Inventor: WOBBEN ALOYS
IPC: F03D80/70
Filed: 2002-01-15
Abstract: In a wind power installation with a (hollow) axis tube member and a hollow shaft mounted thereon for the rotor there is provided only a single bearing which also carries moments, between the axis tube member and the hollow shaft, whereby the parts of the machine which are to be fixed to the machine carrier and thus on the top of the pylon are of a markedly lower weight without the required orientation between the rotating and stationary parts of the electrical generator being adversely affected. In that arrangement the rotating part of the generator is radially aligned substantially with the bearing. The bearing to be used is in particular a twin-row inclined roller bearing with rows of rollers arranged at an angle of about 45 degrees to each other.
Patent NZ-529670-A (NZ)
Title: Benzoxazepine derivatives and their use as AMPA receptor stimulators
Inventor: GROVE SIMON JAMES ANTHONY
IPC: A61P25/28
Filed: 2002-06-05
Abstract: A benzoxazepine derivative of formula (I) and a pharmaceutically acceptable salt thereof are disclosed, wherein X represents CO or SO2; R1, R2, R3 and R4 are independently selected from H, (C1-4)alkyl, (C1-4)alkyloxy, (C1-4)alkyloxy(C1-4)alkyl, halogen, nitro, cyano, NR8R9, NR8COR10, and CONR8R9, R5; R6 and R7 are independently H or (C1-4)alkyl; R8 and R9 are independently H or (C1-4)alkyl; or R8 and R9 form together with the nitrogen atom to which they are bound a 5- or 6-membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O, S or NR11; R10 is (C1-4)alkyl; R11 is (C1-4)alkyl; A represents the residue of a 4-7 membered saturated heterocyclic ring, optionally containing an oxygen atom, the ring being optionally substituted with 1-3 substituents selected from (C1-4)alkyl, (C1-4)alkyloxy, hydroxy, halogen and oxo. Pharmaceutical compositions comprising these benzoxazepine derivatives are suitable in the treatment of neurological diseases and psychiatric disorders which are responsive to enhancement of synaptic responses mediated by AMPA receptors in the central nervous system.
Patent NZ-535468-A (NZ)
Title: Tick galectin
Inventor: NAGASAWA HIDEYUKI
IPC: A61K35/646
Filed: 2003-02-28
Abstract: Described is a polypeptide that is selected from: (1) a polypeptide that consists of the amino acid sequence of SEQ ID NO:2; (2) a polypeptide that comprises the amino acid sequence of SEQ ID NO:2 and exhibits galectin activity; (3) a polypeptide exhibiting a galectin activity and comprising an amino acid sequence in which 1 to 10 amino acids are substituted, deleted, and/or inserted at one or more places in the amino acid sequence of SEQ ID NO:2; or (4) a polypeptide that comprises an amino acid sequence that has a 60% or more homology with the amino acid sequence of SEQ ID NO:2 and exhibiting a galectin activity. Also described is a vector and isolated transformant that comprises the polynucleotide, a medicament which is a tick vaccine and a method for exterminating ticks.
Patent NZ-537164-A (NZ)
Title: Fungicidal mixtures based on dithianon
Inventor: AMMERMANN EBERHARD
Filed: 2003-06-30
Abstract: Disclosed are fungicidal mixtures containing in a synergistically effective amount the compound of formula I and the compound of formula II-3, the mixture may additionally comprise a selected azole derivative. Also disclosed are methods for controlling harmful fungi by using mixtures of compounds I and II-3.
Patent NZ-539155-A (NZ)
Title: Call operating panel for elevator with configurable touch sensitive buttons
Inventor: FELDER HUGO
IPC: B66B3/00
Filed: 2005-03-30
Abstract: A call operation panel 1 for an elevator car includes a set of touch sensitive call buttons 6. The buttons can be configured to correspond to the floors of a building in accordance with a specified configuration. When a button is active in the specified configuration it is lighted as at 9 to be visible to the user. When a particular button is not active in the specified configuration it is not lighted as at 10 so that it is not visible to the user.
Patent NZ-543840-A (NZ)
Title: Prostate stem cell antigen (PSCA) variants and subsequences thereof, namely SEQ ID NO:6537
Inventor: JAKOBOVITS AYA
IPC: C12N5/095
Filed: 2004-05-28
Abstract: Provided is an isolated polynucleotide encoding PSCA protein with a specified DNA sequence, a process for producing the protein using a vector in a host cell and an antibody binding to an epitope in the said protein. Also provided are in vitro methods of detecting the PSCA protein using the claimed compositions and use of the compositions in the manufacture of medicaments to inhibit growth of cells expressing the PSCA protein.
Patent NZ-544774-A (NZ)
Title: Novel polypeptides and polynucleotides
Inventor: AGARWAL PANKAJ
Filed: 2001-09-13
Abstract: Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table I in diagnostic assays.
Patent NZ-546787-A (NZ)
Title: Pyridine compounds as inhibitors of dipeptidyl peptidase IV
Inventor: OI SATORU
IPC: C07D401/06
Filed: 2004-10-29
Abstract: Disclosed is a compound represented by the formula I wherein R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted hydroxy group; R3 is an optionally substituted aromatic group; R4 is an amino group; L is a C1-10 alkylene group; Q is a bond or a divalent chain hydrocarbon group; wherein the rest of the substituents are disclosed within the specification or a salt thereof. Also disclosed is a peptidase inhibitor comprising a compound of any one of claims 1-8 or a salt thereof or a prodrug thereof.
Patent NZ-548041-A (NZ)
Title: Crystal form of quinoline compound and process for its production
Inventor: OHARA YOSHIO
IPC: A61K31/47
Filed: 2004-12-17
Abstract: Disclosed is a crystal of a compound of formula (1), containing 5-15% w/w water and with an X-ray diffraction peak as described in the specification. Also disclosed is a process for producing the crystal, comprising adding a calcium compound to a precursor compound as described in the specification dissolved in water or in a C1-4 alcohol containing at least 60% v/v water.
Patent NZ-560535-A (NZ)
Title: Elisa assays using prion-specific peptide reagents
Inventor: PERETZ DAVID
IPC: C07K14/47
Filed: 2006-01-13
Abstract: A method for detecting a pathogenic prion protein. A solid support that comprises a peptide reagent from SEQ ID NOs 12-260 is used to bind a prion protein in a sample to form a complex. Any unbound material is removed and the prion is the dissociated from the complex with either (i) salt or chaotropic agent or (ii) high or low pH. The dissociated prion is then detected using a prion-binding reagent. The prion maybe denatured during dissociated from the complex and the prion-binding reagent maybe an anti-prion antibody.
Patent NZ-560612-A (NZ)
Title: Polypeptides from staphylococcus aureus and methods of use
Inventor: EMERY DARYLL A
IPC: A61K39/085
Filed: 2006-02-14
Abstract: Provided is a composition comprising: at least five isolated polypeptides having molecular weights of 88 kDa, 55 kDa, 38 kDa, 37 kDa, 36 kDa, 35 kDa or 33 kDa, wherein molecular weight is determined by electrophoresis on a sodium dodecyl sulfate-polyacrylamide gel, wherein the polypeptides are isolatable from a Staphylococcus aureus when incubated in media comprising an iron chelator and not isolatable when grown in the media without the iron chelator, and wherein the composition protects an animal against challenge with S. aureus ATCC strain 19636. Further different combinations of the peptides are also provided.
Patent NZ-564245-A (NZ)
Title: Venting container with venting button in rim of lid
Inventor: MAXWELL JASON R
IPC: B65D41/18
Filed: 2006-06-05
Abstract: A venting container (10) includes a lid (40) and a base (20) having an inner cavity and a side wall (24) that terminates in a rim (28), the lid including a central panel (42) and a peripheral sealing lip (44) that surrounds the panel, the peripheral sealing lip having a generally inverted U-shaped cross section that defines a lid channel into which the container rim fits. The sealing lip includes at least one venting feature in the form of a flexible venting button (52) that is adapted to transition from a first position to a second position upon application of an actuation force, the venting button being further adapted and positioned whereby when the container rim is positioned in the lid channel and the venting button is in the first position, sealed engagement of the lid to the container is effectuated and when the venting button is in the second position a venting air passage is provided from the container cavity to the container surroundings.
Patent NZ-572266-A (NZ)
Title: Pigments comprising amino phosphoryl treated titanium dioxide
Inventor: EL-SHOUBARY MODASSER
IPC: C01G23/047
Filed: 2006-11-13
Abstract: Disclosed is a pigment comprising titanium dioxide that has been treated with an amino phosphoryl compound, wherein the amino phosphoryl compound is represented by one of the formulae (a), (b), (c) or (d); wherein R-, R1, R2, R3, and R4 are the same or different and are H or hydrocarbyl; X, X1, X2, and X3 are the same or different and are H, hydrocarbyl, ammonium, alkylammonium, or an alkali metal; and y = 0 or 1.
Patent NZ-573246-A (NZ)
Title: Weapon grip assembly
Inventor: GRIFFINS TODD
IPC: F41C23/16
Filed: 2004-02-10
Abstract: A multipurpose forend grip assembly is disclosed for integration with a firearm and has a hand grip, a weapon receiving fixture and an accessory module. (62) Divided Out of 545384
Patent NZ-574713-A (NZ)
Title: Surgical retractor fixing device with clamping to longitudinal frameset and bind plate within rotatable body to clamp circular retractor shaft
Inventor: FRICKE HELMUT
IPC: A61B19/00
Filed: 2007-08-17
Abstract: Disclosed is a surgical retractor fixing device, comprising: (a) a clamp body (16) arranged for removably fixing the surgical retractor fixing device (10) to a frameset (93) that extends along a frameset longitudinal axis (L) and that is arranged to be mounted to an operating table; (b) a rotating body (14) attached to the clamp body (16); (c) the rotating body (14) being pivotable around an axis of rotation (A); (d) the rotating body (14) comprising a fixing element (32) arranged for fixing a surgical retractor(12) where in that the fixing element is a releasable one-way fixing element (32).
Patent NZ-574956-A (NZ)
Title: A milking implement having a frame and an arm connected to the frame with a teat cup holder and teat cup movable relative thereto
Inventor: VAN DEN BERG KAREL
IPC: A01J5/003
Filed: 2007-08-15
Abstract: A milking implement is disclosed. The milking implement comprises: (a) a frame (10) with at least one teat cup holder with a teat cup (28) movable relative thereto; and (b) a replacing means connected with the teat cup (28). The frame further comprises an intermediate arm (30) connected with the frame and with the teat cup holder (26) and has a first joint and a second joint about which the teat cup holder (26) and the intermediate arm (30), respectively, are tiltable with the aid of the replacing means. A teat cup holder positioning means is coupled with the teat cup holder (26) and the frame (10) and, if desired, with the intermediate arm (30).
Patent NZ-577603-A (NZ)
Title: Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
Inventor: CHOUDHURY ANUSUYA
IPC: C07D403/10
Filed: 2007-12-10
Abstract: Disclosed is a process for the preparation of formula (Ia) or a pharmaceutically acceptable salt, ester, tautomer, solvate or amide thereof, wherein reacting a compound of formula (Xa) with a compound of formula (XIa) in the presence of a peptide coupling agent, in an organic solvent or mixture of organic solvents, to yield the corresponding compound of formula (Ia). Further disclosed is a process for the preparation of formula (Ib) or a pharmaceutically acceptable salt, ester, tautomer, solvate or amide thereof, wherein reacting a compound of formula (Xb) with a compound of formula (XIb) in the presence of a peptide coupling agent, in an organic solvent or mixture of organic solvents, to yield the corresponding compound of formula (Ib).
Patent NZ-578813-A (NZ)
Title: Energy efficient methods to produce alcohols and carboxylic acids
Inventor: VERSER DAN W
IPC: C12P7/52
Filed: 2008-02-11
Abstract: A method for producing an alcohol or carboxylic acid from a carbohydrate containing material, wherein the chemical energy efficiency of the method is greater than the chemical energy efficiency of a solely biological conversion process, and is greater than a process in which all the material is initially subjected to a thermochemical conversion step. The method comprises the steps: (I) Converting a material that has less than 75 percent by weight of the carbon containing material as carbohydrate into two intermediates. One intermediate is produced by a biological fermentation, and the other intermediate is produced by a thermochemical conversion process selected from gasification, pyrolysis, reforming and partial oxidation; and (II) Reacting the two intermediates to form an alcohol, carboxylic acid, salt or ester of a carboxylic acid. The microorganism used in the biological conversion can be a homofermentative microorganism
Patent NZ-580730-A (NZ)
Title: A liquid formulation for administering nicotine
Inventor: HEDENSTROM JOHN
IPC: A24B15/00
Filed: 2008-04-21
Abstract: Disclosed herein is a liquid formulation for administering nicotine, which is a medicated body lotion which comprises a solvent and nicotine, which is for transdermal administration of nicotine to a subject, which is devoid of tobacco and which is devoid of any uncrosslinked, water-insoluble vinylpyrrolidone copolymer being copolymerizable with a hydrophobic comonomer, and which further comprises one or more additives selected from the group consisting of moisturising agents, sunscreen agents, anti-wrinkle agents, vitamins and perfumes.
Patent NZ-581326-A (NZ)
Title: an open air sport stadium with a retractable partitioning structure
Inventor: FLETCHER PAUL
IPC: E04H3/14
Filed: 2007-04-24
Abstract: 581326 Disclosed is an open air sports stadium (10) having a defined area in which an audience can be seated, which defined area can be enclosed for provision of entertainment to the seated audience. The sports stadium includes: a roof (20) extending over the defined area and at least part of a sports playing field; one or more partitioning structures (22) retractable from a fully extended position in which position the defined area is completely enclosed, to a stored position wherein the entire sports playing field is open; and means for supporting the partitioning structure in a fully extended position.
Patent NZ-585720-A (NZ)
Title: Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof
Inventor: FOWLER ANN
IPC: A23L33/00
Filed: 2008-12-03
Abstract: Disclosed herein is the use of a composition consisting essentially of: steviol, isosteviol and mixtures thereof for the manufacture of a medicament for the treatment of depression, anxiety, mood disorders, age related cognitive decline, stress related cognitive dysfunction in an animal or human, wherein the composition comprises 100-500mg of steviol and/or isosteviol.
Patent NZ-589863-A (NZ)
Title: Genetic markers for weight management and methods of use thereof
Inventor: KREMPIN DAVID
IPC: A23L33/20
Filed: 2009-05-15
Abstract: Provided is a method for selecting a therapeutic/dietary regimen or lifestyle recommendation for a subject comprising: a) assaying a nucleic acid sample obtained from the subject and determining the subject's genotype with respect to the polymorphic loci comprising: FABP2 (rsI799883; G/A) locus; PPARG (rsI801282; C/G) locus; and ADRB2 (rs1042714; C/G) locus; and b) classifying the subject based on said subject's genotype with respect to the polymorphic loci, wherein when the subject's genotype is FABP2 (rs1799883) G/G; PPARG (rs1801282) C/C; and ADRB2 (rs1042714) C/C, then selecting a dietary regimen for the subject, that is a balanced diet.
Patent NZ-590458-A (NZ)
Title: Bromine-based method and system for converting gaseous alkanes to liquid hydrocarbons using electrolysis for bromine recovery
Inventor: WAYCUILIS JOHN J
IPC: C07C17/00
Filed: 2009-06-12
Abstract: Disclosed here are methods related to conversion of gaseous alkanes to liquid hydrocarbons, particularly, to a method and system that includes bromination of alkanes followed by conversion of the brominated alkanes to hydrocarbons wherein bromine recovery includes electrolysis. Said method comprising: · providing a stream comprising halogenated alkanes; · forming synthesis products comprising hydrocarbons and hydrogen bromide from synthesis reactants comprising at least a portion of the halogenated alkanes, wherein the forming synthesis products occurs at a temperature in the range of about 150°C to about 500° C and at a pressure in the range of about 1 atm to 100 atm; · neutralizing the hydrogen bromide to form a metal bromide salt; and · recovering bromine from the metal bromide salt in an electrolysis unit. Also further disclosed is a method comprising: · forming synthesis products comprising hydrocarbons and hydrogen bromide from synthesis reactants comprising brominated alkanes, wherein the forming synthesis products occurs at a temperature in the range of about 150° C to about 500° C and at a pressure in the range of about 1 atm to 100 atm; · separating the synthesis products into at least a liquid product stream comprising C5+ hydrocarbons and a stream comprising hydrogen bromide and methane ; and · converting at least a portion of the hydrogen bromide to at least molecular bromine using gas phase electrolysis; · providing a stream comprising hydrocarbons; and · forming bromination products by reacting at least a portion of the molecular bromine with at least a portion of the hydrocarbons, wherein the forming of the bromination products occurs at a temperature in the range of about 250º C to about 600º C and at a pressure in the range of about 1 atm to about 100 atm.
Patent NZ-590469-A (NZ)
Title: Treatment of rheumatoid arthritis with human beta defensins (1-4)
Inventor: KJAER TANJA MARIA ROSENKILDE
IPC: A61K38/17
Filed: 2009-07-17
Abstract: Discloses the use a human beta defensin peptide in the manufacture of a medicament for the treatment of rheumatoid arthritis. The disclosed human beta defensin peptide has at least 80 % amino acid identity to SEQ ID NOs:1-4.
Patent NZ-597177-A (NZ)
Title: Polymorph forms of (2S) - (4E) -N-methyl-5-(3-isopropoxypyridin) yl] -4-penten-2-amine for the treatment of central nervous system disorders
Inventor: DULL GARY MAURICE
IPC: A61K31/44
Filed: 2007-05-08
Abstract: 597177 Disclosed herein are crystalline polymorphs A and B of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine p-hydroxybenzoate exhibiting an X-ray powder diffraction pattern as defined in the specification. Additionally disclosed is the polymorph when isolated by recrystallization from ethanol, methanol, isopropyl alcohol, acetone, ethyl acetate or acetonitrile. Additionally disclosed is the use of the polymorph in the treatment of a central nervous system disorder.
Patent NZ-597949-A (NZ)
Title: Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound having specific structure
Inventor: YAMAGUCHI YOSHIMASA
IPC: C07D471/10
Filed: 2007-10-15
Abstract: Disclosed is the use of a heterocyclic compound of formula (I), wherein the substituents are as described within the specification, in the manufacture of a medicament for treatment by inhibiting amyloid beta deposition, amyloidosis, cerebral amyloid angiopathy, cataract, glaucoma, the progression of glaucoma age-related macular degeneration, rheumatism, osteoporosis, metabolic syndrome, wrinkles, and hair loss.